Patents by Inventor Hassan JAVANBAKH

Hassan JAVANBAKH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIGOMERS AND OLIGOMER CONJUGATES
    Publication number: 20240035032
    Abstract: The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
    Type: Application
    Filed: February 27, 2023
    Publication date: February 1, 2024
    Applicant: Hoffmann-La roche Inc.
    Inventors: Hassan JAVANBAKH, Søren OTTOSEN, Morten LINDOW
  • Oligomers and oligomer conjugates
    Patent number: 11591598
    Abstract: The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: February 28, 2023
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Hassan Javanbakh, Søren Ottosen, Morten Lindow
  • OLIGOMERS AND OLIGOMER CONJUGATES
    Publication number: 20210054381
    Abstract: The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
    Type: Application
    Filed: September 4, 2020
    Publication date: February 25, 2021
    Applicant: Hoffmann-La roche Inc.
    Inventors: Hassan JAVANBAKH, Søren OTTOSEN, Morten LINDOW
  • Oligomers and oligomer conjugates
    Patent number: 10767181
    Abstract: The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: September 8, 2020
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Hassan Javanbakh, Søren Ottosen, Morten Lindow
  • OLIGOMERS AND OLIGOMER CONJUGATES
    Publication number: 20200024605
    Abstract: The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
    Type: Application
    Filed: August 2, 2019
    Publication date: January 23, 2020
    Applicant: Hoffmann-La roche Inc.
    Inventors: Hassan Javanbakh, Søren Ottosen, Morten Lindow
  • Oligomers and oligomer conjugates
    Patent number: 10421967
    Abstract: The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: September 24, 2019
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Hassan Javanbakh, Søren Ottosen, Morten Lindow
  • OLIGOMERS AND OLIGOMER CONJUGATES
    Publication number: 20160010093
    Abstract: The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
    Type: Application
    Filed: May 15, 2015
    Publication date: January 14, 2016
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Hassan JAVANBAKH, Søren OTTOSEN, Morten LINDOW